DEEP RESEARCH · Samsung C&T (028260)

Samsung C&T — Portfolio Transformation and the Re-rating Inflection

Construction (P5 returns) · Trading (solar organizer) · Bio (Plant 5) · Shareholder return (new 2026 policy) — four axes audited

Date: 2025-12-19 · Based on 2025 Q3 results and consensus · Source: Naver Blog

0. Bottom line first

1. Beyond the conglomerate dilemma

Samsung C&T is effectively the Samsung Group's holding company and a conglomerate spanning construction, trading, fashion, leisure, and bio. Past valuation relied on a simple SOTP of core operations + equity holdings. Recent strategic moves accelerate the shift from "managed holding company" to "high-margin portfolio organizer."

2. Q3-2025 financial review

2.1 Consolidated headline — bio drives earnings-quality lift

Official fact: Q3-2025 consolidated preliminary revenue KRW 10.15 trn, operating profit KRW 994 bn. YoY revenue -1.5%, operating profit +35.1%. OPM 9.8% (vs 7.1%, +2.7pp).

2.2 Segment breakdown (Q3-2025)

Interpretation: Bio carries ~72.6% of Q3 OP. Construction is the laggard (OP -53%) — P3 completed, P4/P5 not yet at full pace. Cumulative orders KRW 12.21 trn + rising overseas share lay the foundation for recovery. Trading shifts from pure trading margins toward project-development gains — cumulative US solar divestment gains $29.8 mn.

3. Construction — HiTech returns + next-gen energy

3.1 P5 restart = 2026 rebound

Official fact: Samsung Electronics resumes Pyeongtaek Plant 5 (P5) investment. PC excavation and foundation work begin mid-December 2025; full-scale work to ramp April 2026. Already booked ~KRW 2.2 trn for P4 finishing (Ph4) in Q3-2025.

P5 targets finishing by 2027 and operation by 2H-2028 → 3-4 years of stable revenue base.

3.2 Energy solutions — SMR + renewables

• SMR: Stake / partnership with NuScale Power (US) → MOU with Synthos Green Energy (Poland) → participated in Romania SMR FEED. Validated 'modularized steel-plate concrete construction' — proves EPC capability. Material order and revenue contribution expected from 2026.
• Global renewables: KRW 1 trn of Australian renewables/HVDC orders in 2025 alone. Qatar solar plant order worth KRW 1.5 trn.

4. Trading — differentiated "organizer" model

4.1 Three-way comparison

4.2 Solar — a recurring profit model

• 9M-2025 cumulative solar divestment gains $29.8 mn (~KRW 40 bn), with more closings expected in Q4.
• Pipeline 21.9 GW (more than double 2021). Now established as a recurring profit model rather than one-off gains.

4.3 2026 commodities backdrop

• Oil: Goldman / JPM see 2026 Brent ~$60/bbl — a trading-margin headwind, but limited risk for Samsung C&T given low direct resource ownership.
• Copper: AI datacenter + power-grid demand supports $10,000–11,000/t. Steel demand recovery limited by Chinese supply + trade barriers. Battery recycling and copper trading offset volatility.

5. Bio — the heart of group earnings

• Q3-2025 OPM 40%+ — breaks the manufacturing ceiling.
• Plant 5 (180 kL) on stream takes total capacity to 784 kL, cementing #1 CDMO position.
• In 2026, Plant 5 utilization ramp + ADC-dedicated facility → revenue/profit step-up and earnings-quality uplift.

6. Governance & valuation — the key to closing the discount

6.1 NAV discount and the SK Inc. comparison

Samsung C&T's market cap is well below its listed-affiliate stakes (Samsung Electronics, Samsung Biologics, Samsung Life). NAV discount is over 60%. SK Inc.'s discount reflects SK On losses + reshuffle-risk premium. Samsung C&T's discount stems from conservative capital allocation + governance (inheritance-tax) uncertainty, despite a strong balance sheet.

6.2 The 2026 shareholder-return policy

The current 3-year policy (2023-2025) returns 60-70% of affiliate dividend income and cancels all treasury stock (13.2% common, 9.8% preferred). Cancellations are proceeding on plan, with completion targeted by 2026. The new policy (2026-2028), due early 2026, is expected to include:

1. Higher payout: with fewer shares outstanding post-cancellation, DPS rises structurally. The market expects fixing the upper end of the payout range or adding a minimum DPS floor.
2. Alignment with Korea's "Value-Up" program: explicit ROE targets and possibly special dividends from non-core asset sales.
3. Equity-value reset: full treasury cancellation lifts per-share NAV directly — 2026 could be the start of the re-rating.

7. 2026 outlook & conclusion

7.1 Consensus

• Revenue: KRW 42.8 trn – 44.3 trn (YoY ~+7%).
• Operating profit: KRW 3.6 trn – 3.7 trn (YoY ~+13%).
• Drivers: full Plant 5 contribution; construction recognition of P5 / large overseas projects; consumer rebound aided by rate cuts.

7.2 Conclusion — the re-rating conditions are in place

2025 proved earnings stability: bio offset construction softness. 2026 should bring across-the-board turnaround + an upgraded shareholder-return policy → a real re-rating. Low PBR and a deep NAV discount paradoxically provide a meaningful margin of safety.

Key takeaways

1. HiTech returns: P5 groundbreaking late-2025 → 2026 construction profit rebound.
2. Bio engine accelerates: Plant 5 (Apr 2025) + ADC market entry.
3. Organizer evolution: Trading goes asset-light + solar / battery recycling traction.
4. Shareholder-return optionality: New 2026 policy + full treasury cancellation.